Mergers & Acquisitions (M&A)

Adama to Take Control of China’s Huifeng

Israeli crop protection producer Adama has entered into an agreement that will see it take a majority stake in most of Huifeng Bio Agriculture’s synthesis and formulation facilities.

Catalent to Acquire Belgium’s Bone Therapeutics

US-based CDMO Catalent has agreed to acquire Bone Therapeutics’ cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support (SCTS), in Gosselies, Belgium, for $14 million.

Sanofi Strengthens Immunology with Kiadis Buy

French pharma Sanofi is boosting once again its immunology portfolio with an agreement to buy Dutch biotech Kiadis for €308 million.

Bayer Takes AskBio in $4 Billion Deal

In its biggest pharma acquisition since the 2006 takeover of Berlin-based women’s specialist Schering, Bayer plans to plunk down up to $4 billion for US biotech firm Asklepios BioPharmaceutical (AskBio). Under the agreed terms, Bayer will pay $2 billion upfront and up to $2 billion more, contingent on certain success milestones.

Barentz Acquires Asian Distributor

Leading global distributor of life science ingredients Barentz has expanded its activities in the Asian life science markets with the acquisition of Singapore-headquartered Nardev, a distributor specialized in the personal care market. Financial details were not disclosed.

PQ Sells Performance Materials to Private Equity

US specialty chemicals company PQ Group has agreed to sell its Performance Materials business to middle-market private equity firm The Jordan Company (TJC) for $650 million. The sale is expected to close by the end of 2020, subject to regulatory approvals and customary conditions.

Barentz Buys US Maroon Group

Barentz, a Dutch distributor of life science ingredients, has agreed to acquire Maroon Group in the US for an undisclosed sum. The deal, which significantly extends Barentz’s footprint in North America, is expected to close by the end of this year.

Kymos Acquires Germany’s Prolytic

Spanish contract laboratory company Kymos has boosted its European presence with the takeover of Germany’s Prolytic. Financial details were not disclosed.

Saudi Groups Start Merger Discussions

Resurrecting plans from nine years ago, National Petrochemical (Petrochem) and Saudi Industrial Investment Group (SIIG) have initiated discussions about the economic feasibility of a merger.

Gilead Takes Immunomedics for $21 Billion

Gilead Sciences is to acquire Immunomedics for approximately $21 billion. The deal, unanimously approved by both companies' boards of directors, will be funded by $15 billion in cash and $6 billion in new debt, and is expected to close during the fourth quarter of 2020.

Expansions in High-Potency API Manufacturing

DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.

Evonik Acquiring Porocel for $210 Million

In a move designed to boost its catalyst business, Evonik will pay $210 million to acquire the Porocel Group, a US technology provider based in Houston, Texas. The transaction, to be financed out of Evonik's “strong cash position,” is due to close by the end of 2020 subject to regulatory approval.

Brenntag Boosts Lubricants with Oils ‘R Us Buy

Leading chemicals distributor Brenntag has agreed to buy Oils ‘R US, a Thai distributor of lubricants for automotive, commercial vehicle, industrial and marine applications. The transaction is expected to complete in the second half of 2020.

Mitsubishi Chemical to Acquire US Chemicals and Materials Manufacturer Gelest

Tokyo, Japan-based Mitsubishi Chemical Corporation (MCC), through its US subsidiary acquires US chemicals and materials group Gelest from New Mountain Capital.

AdvanSource Biomaterials Sells TPU Business to Mitsubishi Chemicals

Injecting Growth and Innovation

Chemical Distributor Oqema Acquires Irish Rocara Group

CDMO Market Forces Re-shape of M&A Activity

ACG Acquires Pharma Processing Equipment Provider Xertecs

Atotech Buys J-KEM International

Lanxess to Sell Chrome Chemicals to Brother

Jazz Pharmaceuticals Buys US Biotech Cavion

Mezzan Buys Kuwaiti Pharma Company

FTC Blocks Evonik Takeover of Peroxychem

Brenntag Acquires in South Africa and Taiwan

Evonik’s Sale of Röhm to Advent Closes

With the transfer of Evonik’s methacrylates business to private equity investor Advent International, Röhm, one of the world’s leading producers of methyl methacrylate (MMA) monomer and PMMA molding compounds, is now called Röhm again. The company based at Darmstadt, Germany, also has a new logo.

Arkema to Acquire UK’s Lambson

AkzoNobel to Acquire France’s Mapaero

Bayer and Elanco Animal Health Link-up?

Boehringer Buys AMAL Therapeutics

Pharmaceutical Logistics in the Asian Pacific Region

Olon Buys Indian API Plant

With this acquisition, Olon said it has successfully finalized its three-year development plan and will now move to its next target, which is to play an important role in manufacturing biologics APIs.

Asian Interest in European Chemical Companies

Safic-Alcan Acquires Italian Chemical Distributor Luigi and Felice Castelli

Air Products Completes ACP Acquisition